ID: 206	RANK: 7	SCORE: 24.528725
<DOC>
<DOCNO> WSJ870401-0106 </DOCNO>
<HL> Eli Lilly &amp; Co. Reduces
Stake in Liposome to 4%</HL>
<DD> 04/01/87</DD>
<SO> WALL STREET JOURNAL (J)</SO>
<IN> LLY LIPO
TENDER OFFERS, MERGERS, ACQUISITIONS (TNM) </IN>
<DATELINE> WASHINGTON  </DATELINE>
<TEXT>
   Eli Lilly &amp; Co. said it lowered its stake in Liposome Co. to 4% of the 12.3 million common shares outstanding. 

   In a filing with the Securities and Exchange Commission, Eli Lilly said it sold 400,000 Liposome common shares March 17 at $8 a share. 
As a result of the sale, Eli Lilly holds 500,000 Liposome common shares for investment purposes, the filing said. 

   According to the filing, Eli Lilly may sell more Liposome stock in the future. 
Eli Lilly officials couldn't be reached for comment. 

   Eli Lilly is an Indianapolis-based maker of medicine, medical instrument systems, agricultural products and cosmetics. 
Liposome is a Princeton, N.J.-based pharmaceutical research concern. 

</TEXT>
</DOC>
